{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:39:28Z","timestamp":1791661168052,"version":"4.3.4"},"reference-count":130,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s00415-025-13571-6","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T04:42:20Z","timestamp":1766119340000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Brain atrophy in autoimmune encephalitis: epidemiology, pathophysiology, clinical manifestations, treatment, and prognosis\u2014an update"],"prefix":"10.1007","volume":"273","author":[{"given":"Chenyi","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaohua","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muwei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiazheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanyu","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7428-7153","authenticated-orcid":false,"given":"Sheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,19]]},"reference":[{"issue":"8","key":"13571_CR1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2174\/1871527319666200708133103","volume":"19","author":"MS Nissen","year":"2020","unstructured":"Nissen MS et al (2020) Autoimmune encephalitis: current knowledge on subtypes, disease mechanisms and treatment. CNS Neurol Disord Drug Targets 19(8):584\u2013598","journal-title":"CNS Neurol Disord Drug Targets"},{"issue":"8","key":"13571_CR2","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1007\/s00415-023-11685-3","volume":"270","author":"JA Varley","year":"2023","unstructured":"Varley JA et al (2023) Autoimmune encephalitis: recent clinical and biological advances. J Neurol 270(8):4118\u20134131","journal-title":"J Neurol"},{"key":"13571_CR3","doi-asserted-by":"publisher","DOI":"10.1212\/WN9.0000000000000007","author":"KH Wong","year":"2025","unstructured":"Wong KH et al (2025) A phase-2B double-blind randomized international prospective trial of inebilizumab in NMDAR encephalitis: the extinguish trial. Neurol Open Access. https:\/\/doi.org\/10.1212\/WN9.0000000000000007","journal-title":"Neurol Open Access"},{"key":"13571_CR4","doi-asserted-by":"crossref","first-page":"1509143","DOI":"10.3389\/fimmu.2025.1509143","volume":"16","author":"J Zhang","year":"2025","unstructured":"Zhang J et al (2025) Successful sequential therapy with rituximab and telitacicept in refractory anti-NMDA receptor encephalitis and MOG-associated demyelination: a case report and literature review. Front Immunol 16:1509143","journal-title":"Front Immunol"},{"issue":"4","key":"13571_CR5","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1007\/s13311-016-0442-6","volume":"13","author":"WJ Lee","year":"2016","unstructured":"Lee WJ et al (2016) Tocilizumab in autoimmune encephalitis refractory to rituximab: an institutional cohort study. Neurotherapeutics 13(4):824\u2013832","journal-title":"Neurotherapeutics"},{"issue":"3","key":"13571_CR6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.pcl.2023.01.007","volume":"70","author":"JA Vova","year":"2023","unstructured":"Vova JA, Howarth RA (2023) Evaluation, treatment, and outcomes of viral and autoimmune encephalitis in children. Pediatr Clin North Am 70(3):429\u2013444","journal-title":"Pediatr Clin North Am"},{"issue":"1","key":"13571_CR7","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jamaneurol.2016.4226","volume":"74","author":"C Finke","year":"2017","unstructured":"Finke C et al (2017) Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma-inactivated 1 antibodies. JAMA Neurol 74(1):50\u201359","journal-title":"JAMA Neurol"},{"key":"13571_CR8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fneur.2020.00403","volume":"11","author":"F Zhu","year":"2020","unstructured":"Zhu F et al (2020) Clinical characteristics of anti-GABA-B receptor encephalitis. Front Neurol 11:403","journal-title":"Front Neurol"},{"issue":"9","key":"13571_CR9","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.neurol.2024.09.005","volume":"180","author":"B Joubert","year":"2024","unstructured":"Joubert B (2024) The neurobiology and immunology of CASPR2-associated neurological disorders. Rev Neurol (Paris) 180(9):950\u2013956","journal-title":"Rev Neurol (Paris)"},{"issue":"6","key":"13571_CR10","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1001\/jamaneurol.2016.0232","volume":"73","author":"T Iizuka","year":"2016","unstructured":"Iizuka T et al (2016) Association of progressive cerebellar atrophy with long-term outcome in patients with anti-N-methyl-d-aspartate receptor encephalitis. JAMA Neurol 73(6):706\u2013713","journal-title":"JAMA Neurol"},{"issue":"1","key":"13571_CR11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/ene.13180","volume":"24","author":"CG Bien","year":"2017","unstructured":"Bien CG et al (2017) Anti-contactin-associated protein-2 encephalitis: relevance of antibody titres, presentation and outcome. Eur J Neurol 24(1):175\u2013186","journal-title":"Eur J Neurol"},{"issue":"9","key":"13571_CR12","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/brain\/awab153","volume":"144","author":"S Mu\u00f1iz-Castrillo","year":"2021","unstructured":"Mu\u00f1iz-Castrillo S et al (2021) Distinctive clinical presentation and pathogenic specificities of anti-AK5 encephalitis. Brain 144(9):2709\u20132721","journal-title":"Brain"},{"issue":"7","key":"13571_CR13","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1136\/jnnp-2012-303807","volume":"84","author":"Y Hacohen","year":"2013","unstructured":"Hacohen Y et al (2013) Paediatric autoimmune encephalopathies: clinical features, laboratory investigations and outcomes in patients with or without antibodies to known central nervous system autoantigens. J Neurol Neurosurg Psychiatry 84(7):748\u2013755","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"13571_CR14","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.25754","volume":"88","author":"F Bartels","year":"2020","unstructured":"Bartels F et al (2020) Clinical and magnetic resonance imaging outcome predictors in pediatric anti-N-methyl-D-aspartate receptor encephalitis. Ann Neurol 88(1):148\u2013159","journal-title":"Ann Neurol"},{"issue":"9","key":"13571_CR15","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.neurol.2024.08.006","volume":"180","author":"TJ Hartung","year":"2024","unstructured":"Hartung TJ et al (2024) MRI findings in autoimmune encephalitis. Rev Neurol (Paris) 180(9):895\u2013907","journal-title":"Rev Neurol (Paris)"},{"issue":"10","key":"13571_CR16","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1007\/s00415-010-5604-6","volume":"257","author":"T Iizuka","year":"2010","unstructured":"Iizuka T et al (2010) Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol 257(10):1686\u20131691","journal-title":"J Neurol"},{"key":"13571_CR17","doi-asserted-by":"crossref","first-page":"1274672","DOI":"10.3389\/fimmu.2023.1274672","volume":"14","author":"T Sapana","year":"2023","unstructured":"Sapana T et al (2023) A case report of anti-GAD65 antibody-positive autoimmune encephalitis in children associated with autoimmune polyendocrine syndrome type-II and literature review. Front Immunol 14:1274672","journal-title":"Front Immunol"},{"key":"13571_CR18","doi-asserted-by":"crossref","first-page":"805","DOI":"10.2147\/ITT.S498345","volume":"13","author":"S Chen","year":"2024","unstructured":"Chen S et al (2024) Anti-GluK2 encephalitis in an Asian child: a case report and literature review. Immunotargets Ther 13:805\u2013811","journal-title":"Immunotargets Ther"},{"issue":"1","key":"13571_CR19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ana.24979","volume":"82","author":"A Gadoth","year":"2017","unstructured":"Gadoth A et al (2017) Expanded phenotypes and outcomes among 256 LGI1\/CASPR2-IgG-positive patients. Ann Neurol 82(1):79\u201392","journal-title":"Ann Neurol"},{"issue":"18","key":"13571_CR20","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1212\/WNL.0000000000003887","volume":"88","author":"C Gaig","year":"2017","unstructured":"Gaig C et al (2017) Clinical manifestations of the anti-IgLON5 disease. Neurology 88(18):1736\u20131743","journal-title":"Neurology"},{"issue":"10","key":"13571_CR21","doi-asserted-by":"crossref","first-page":"6131","DOI":"10.1007\/s10072-022-06244-z","volume":"43","author":"D Reis Carneiro","year":"2022","unstructured":"Reis Carneiro D et al (2022) Sez6l2-associated encephalitis in a patient with small-cell lung cancer. Neurol Sci 43(10):6131\u20136133","journal-title":"Neurol Sci"},{"issue":"10","key":"13571_CR22","doi-asserted-by":"crossref","first-page":"3509","DOI":"10.1093\/brain\/awac166","volume":"145","author":"W-J Lee","year":"2022","unstructured":"Lee W-J et al (2022) Seronegative autoimmune encephalitis: clinical characteristics and factors associated with outcomes. Brain 145(10):3509\u20133521","journal-title":"Brain"},{"issue":"7","key":"13571_CR23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/acn3.51604","volume":"9","author":"W-J Lee","year":"2022","unstructured":"Lee W-J et al (2022) Disease progression and brain atrophy in NMDAR encephalitis: associated factor & clinical implication. Ann Clin Transl Neurol 9(7):912\u2013924","journal-title":"Ann Clin Transl Neurol"},{"issue":"14","key":"13571_CR24","doi-asserted-by":"crossref","first-page":"e1367","DOI":"10.1212\/WNL.0000000000012639","volume":"97","author":"C Gaig","year":"2021","unstructured":"Gaig C et al (2021) Frequency and characterization of movement disorders in anti-IgLON5 disease. Neurology 97(14):e1367\u2013e1381","journal-title":"Neurology"},{"key":"13571_CR25","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awaf256","author":"SM Yogeshwar","year":"2025","unstructured":"Yogeshwar SM et al (2025) Brain atrophy patterns in anti-IgLON5 disease. Brain\u202f: A J Neurol. https:\/\/doi.org\/10.1093\/brain\/awaf256","journal-title":"Brain : A J Neurol"},{"key":"13571_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103701","author":"M Dade","year":"2020","unstructured":"Dade M et al (2020) Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms21103701","journal-title":"Int J Mol Sci"},{"issue":"1","key":"13571_CR27","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s13052-024-01727-5","volume":"50","author":"D Liao","year":"2024","unstructured":"Liao D et al (2024) Clinical characteristics and long-term outcome of CASPR2 antibody-associated autoimmune encephalitis in children. Ital J Pediatr 50(1):158","journal-title":"Ital J Pediatr"},{"key":"13571_CR28","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001039","author":"AEM Bastiaansen","year":"2021","unstructured":"Bastiaansen AEM et al (2021) Autoimmune encephalitis resembling dementia syndromes. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001039","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"13571_CR29","doi-asserted-by":"crossref","first-page":"19138","DOI":"10.1038\/s41598-024-69726-4","volume":"14","author":"S Sato","year":"2024","unstructured":"Sato S et al (2024) Association of olfactory and cognitive function test scores with hippocampal and amygdalar grey matter volume: a cross-sectional study. Sci Rep 14(1):19138","journal-title":"Sci Rep"},{"issue":"1","key":"13571_CR30","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/ana.21050","volume":"61","author":"J Dalmau","year":"2007","unstructured":"Dalmau J et al (2007) Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 61(1):25\u201336","journal-title":"Ann Neurol"},{"issue":"5","key":"13571_CR31","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ana.26223","volume":"90","author":"T Zrzavy","year":"2021","unstructured":"Zrzavy T et al (2021) Neuropathological variability within a spectrum of NMDAR-encephalitis. Ann Neurol 90(5):725\u2013737","journal-title":"Ann Neurol"},{"issue":"3","key":"13571_CR32","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.cardfail.2008.10.020","volume":"15","author":"MA Woo","year":"2009","unstructured":"Woo MA et al (2009) Brain injury in autonomic, emotional, and cognitive regulatory areas in patients with heart failure. J Card Fail 15(3):214\u2013223","journal-title":"J Card Fail"},{"key":"13571_CR33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/1471-2377-14-145","volume":"14","author":"T G\u00f6tz","year":"2014","unstructured":"G\u00f6tz T et al (2014) Long-term sequelae of severe sepsis: cognitive impairment and structural brain alterations - an MRI study (LossCog MRI). BMC Neurol 14:145","journal-title":"BMC Neurol"},{"issue":"1","key":"13571_CR34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.maturitas.2014.02.013","volume":"78","author":"C Annweiler","year":"2014","unstructured":"Annweiler C et al (2014) Vitamin D and brain volumetric changes: systematic review and meta-analysis. Maturitas 78(1):30\u201339","journal-title":"Maturitas"},{"issue":"1\u20132","key":"13571_CR35","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jns.2005.03.006","volume":"233","author":"R Zivadinov","year":"2005","unstructured":"Zivadinov R (2005) Steroids and brain atrophy in multiple sclerosis. J Neurol Sci 233(1\u20132):73\u201381","journal-title":"J Neurol Sci"},{"issue":"4","key":"13571_CR36","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/ana.410380423","volume":"38","author":"O Papazian","year":"1995","unstructured":"Papazian O et al (1995) Reversible dementia and apparent brain atrophy during valproate therapy. Ann Neurol 38(4):687\u2013691","journal-title":"Ann Neurol"},{"issue":"3","key":"13571_CR37","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1017\/S0317167100026640","volume":"14","author":"RS McLachlan","year":"1987","unstructured":"McLachlan RS (1987) Pseudoatrophy of the brain with valproic acid monotherapy. Can J Neurol Sci 14(3):294\u2013296","journal-title":"Can J Neurol Sci"},{"issue":"5","key":"13571_CR38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00415-025-13094-0","volume":"272","author":"L Campetella","year":"2025","unstructured":"Campetella L et al (2025) Neurodegeneration and the immune system: lessons from autoimmune encephalitis. J Neurol 272(5):359","journal-title":"J Neurol"},{"key":"13571_CR39","doi-asserted-by":"crossref","first-page":"1333658","DOI":"10.3389\/fneur.2024.1333658","volume":"15","author":"X Chen","year":"2024","unstructured":"Chen X et al (2024) Cerebellar encephalitis associated with anti-mGluR1 antibodies: a case report and comprehensive literature review. Front Neurol 15:1333658","journal-title":"Front Neurol"},{"issue":"9","key":"13571_CR40","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2014-308814","volume":"86","author":"M Dogan Onugoren","year":"2015","unstructured":"Dogan Onugoren M et al (2015) Limbic encephalitis due to GABAB and AMPA receptor antibodies: a case series. J Neurol Neurosurg Psychiatry 86(9):965\u2013972","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13571_CR41","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.clinimag.2021.05.028","volume":"78","author":"FC Bassal","year":"2021","unstructured":"Bassal FC et al (2021) Anti-NMDA receptor encephalitis and brain atrophy in children and adults: a quantitative study. Clin Imaging 78:296\u2013300","journal-title":"Clin Imaging"},{"key":"13571_CR42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2022.577861","volume":"367","author":"I McKeon-Makki","year":"2022","unstructured":"McKeon-Makki I et al (2022) Adenylate kinase 5 (AK5) autoimmune encephalitis: Clinical presentations and outcomes in three new patients. J Neuroimmunol 367:577861","journal-title":"J Neuroimmunol"},{"key":"13571_CR43","volume":"7","author":"E-C Li","year":"2023","unstructured":"Li E-C et al (2023) Anti-adenylate kinase 5 encephalitis: clinical characteristics, diagnosis, and management of this rare entity. J Transl Autoimmun 7:100218","journal-title":"J Transl Autoimmun"},{"key":"13571_CR44","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001019","author":"G Ricken","year":"2021","unstructured":"Ricken G et al (2021) Autoimmune global amnesia as manifestation of AMPAR encephalitis and neuropathologic findings. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000001019","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13571_CR45","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2018-227893","author":"N Urriola","year":"2019","unstructured":"Urriola N et al (2019) Fulminant thymomatous AMPAR-antibody limbic encephalitis with hypertonic coma, bruxism, an isoelectric electroencephalogram and temporal cortical atrophy, with recovery. BMJ Case Rep. https:\/\/doi.org\/10.1136\/bcr-2018-227893","journal-title":"BMJ Case Rep"},{"issue":"1\u20132","key":"13571_CR46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jns.2014.03.043","volume":"341","author":"C-H Lee","year":"2014","unstructured":"Lee C-H et al (2014) Caspr2 antibody limbic encephalitis is associated with Hashimoto thyroiditis and thymoma. J Neurol Sci 341(1\u20132):36\u201340","journal-title":"J Neurol Sci"},{"key":"13571_CR47","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200041","author":"J Benoit","year":"2023","unstructured":"Benoit J et al (2023) Early-stage contactin-associated protein-like 2 limbic encephalitis: clues for diagnosis. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200041","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13571_CR48","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2023.106221","volume":"184","author":"T Kirschstein","year":"2023","unstructured":"Kirschstein T, K\u00f6hling R (2023) Functional changes in neuronal circuits due to antibody-driven autoimmune response. Neurobiol Dis 184:106221","journal-title":"Neurobiol Dis"},{"issue":"4","key":"13571_CR49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1007\/s00415-019-09686-2","volume":"267","author":"M Boyko","year":"2020","unstructured":"Boyko M et al (2020) Systematic review of the clinical spectrum of CASPR2 antibody syndrome. J Neurol 267(4):1137\u20131146","journal-title":"J Neurol"},{"issue":"12","key":"13571_CR50","volume":"15","author":"A Esechie","year":"2023","unstructured":"Esechie A et al (2023) A devastating neurological disorder: anti-Dipeptidyl-Peptidase-Like Protein 6 (DPPX) encephalitis causing rapidly progressive dementia. Cureus 15(12):e51123","journal-title":"Cureus"},{"key":"13571_CR51","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2024.578501","volume":"399","author":"M Gilligan","year":"2025","unstructured":"Gilligan M et al (2025) A complex and severe encephalitis associated with four co-existing neuronal cell-surface autoantibodies. J Neuroimmunol 399:578501","journal-title":"J Neuroimmunol"},{"key":"13571_CR52","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.neuroscience.2018.11.003","volume":"395","author":"LG Kammel","year":"2018","unstructured":"Kammel LG et al (2018) Enhanced GABAergic tonic inhibition reduces intrinsic excitability of hippocampal CA1 pyramidal cells in experimental autoimmune encephalomyelitis. Neuroscience 395:89\u2013100","journal-title":"Neuroscience"},{"issue":"3","key":"13571_CR53","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000552","volume":"6","author":"K O'Connor","year":"2019","unstructured":"O\u2019Connor K et al (2019) GABA(A) receptor autoimmunity: a multicenter experience. Neurol Neuroimmunol Neuroinflamm 6(3):e552","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"6","key":"13571_CR54","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1007\/s12311-024-01729-3","volume":"23","author":"T Yasumoto","year":"2024","unstructured":"Yasumoto T et al (2024) Acute cerebellar manifestations without limbic involvement in GABA(B) receptor autoimmune encephalitis: case report and literature review. Cerebellum (London, England) 23(6):2650\u20132654","journal-title":"Cerebellum (London, England)"},{"issue":"6","key":"13571_CR55","first-page":"424","volume":"4","author":"A Sharma","year":"2012","unstructured":"Sharma A et al (2012) GAD65 positive autoimmune limbic encephalitis: a case report and review of literature. J Clin Med Res 4(6):424\u2013428","journal-title":"J Clin Med Res"},{"key":"13571_CR56","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2021.102826","volume":"32","author":"M Dade","year":"2021","unstructured":"Dade M et al (2021) Quantitative brain imaging analysis of neurological syndromes associated with anti-GAD antibodies. Neuroimage Clin 32:102826","journal-title":"Neuroimage Clin"},{"key":"13571_CR57","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci10060399","author":"D Endres","year":"2020","unstructured":"Endres D et al (2020) Parkinsonian syndrome with frontal lobe involvement and anti-glycine receptor antibodies. Brain Sci. https:\/\/doi.org\/10.3390\/brainsci10060399","journal-title":"Brain Sci"},{"issue":"1","key":"13571_CR58","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12883-025-04037-3","volume":"25","author":"Z Cheng","year":"2025","unstructured":"Cheng Z et al (2025) Anti-GluK2 antibody-positive autoimmune encephalitis concurrent with multiple myeloma: a case report. BMC Neurol 25(1):27","journal-title":"BMC Neurol"},{"issue":"1","key":"13571_CR59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/ana.26098","volume":"90","author":"J Landa","year":"2021","unstructured":"Landa J et al (2021) Encephalitis with autoantibodies against the glutamate kainate receptors GluK2. Ann Neurol 90(1):101\u2013117","journal-title":"Ann Neurol"},{"issue":"4","key":"13571_CR60","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00401-023-02625-6","volume":"146","author":"E Berger-Sieczkowski","year":"2023","unstructured":"Berger-Sieczkowski E et al (2023) Analysis of inflammatory markers and tau deposits in an autopsy series of nine patients with anti-IgLON5 disease. Acta Neuropathol 146(4):631\u2013645","journal-title":"Acta Neuropathol"},{"key":"13571_CR61","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jns.2017.03.020","volume":"376","author":"M Szots","year":"2017","unstructured":"Szots M et al (2017) Global brain atrophy and metabolic dysfunction in LGI1 encephalitis: a prospective multimodal MRI study. J Neurol Sci 376:159\u2013165","journal-title":"J Neurol Sci"},{"issue":"9","key":"13571_CR62","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1136\/jnnp-2018-320168","volume":"90","author":"C Loane","year":"2019","unstructured":"Loane C et al (2019) Hippocampal network abnormalities explain amnesia after VGKCC-Ab related autoimmune limbic encephalitis. J Neurol Neurosurg Psychiatry 90(9):965\u2013974","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"22","key":"13571_CR63","doi-asserted-by":"crossref","first-page":"e3012","DOI":"10.1212\/WNL.0000000000010854","volume":"95","author":"M Spatola","year":"2020","unstructured":"Spatola M et al (2020) Clinical features, prognostic factors, and antibody effects in anti-mGluR1 encephalitis. Neurology 95(22):e3012\u2013e3025","journal-title":"Neurology"},{"key":"13571_CR64","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106908","volume":"209","author":"E Gomez-Figueroa","year":"2021","unstructured":"Gomez-Figueroa E et al (2021) Brain MRI volumetric changes in the follow-up of patients with anti-NMDAr encephalitis. Clin Neurol Neurosurg 209:106908","journal-title":"Clin Neurol Neurosurg"},{"key":"13571_CR65","volume":"13","author":"Q Long","year":"2022","unstructured":"Long Q et al (2022) Cerebral gray matter volume changes in patients with anti-N-methyl-D-aspartate receptor encephalitis: a voxel-based morphometry study. Front Neurol 13:892242","journal-title":"Front Neurol"},{"issue":"23","key":"13571_CR66","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.2169\/internalmedicine.3029-19","volume":"58","author":"Y Shojima","year":"2019","unstructured":"Shojima Y et al (2019) Clinical characterization of definite autoimmune limbic encephalitis: a 30-case series. Intern Med 58(23):3369\u20133378","journal-title":"Intern Med"},{"issue":"17","key":"13571_CR67","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000006776","volume":"96","author":"H Kataoka","year":"2017","unstructured":"Kataoka H et al (2017) Early progression of brain atrophy in patients with anti-N-methyl-D-aspartate receptor encephalitis: case reports. Medicine (Baltimore) 96(17):e6776","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"13571_CR68","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00415-021-10643-1","volume":"269","author":"J Xu","year":"2022","unstructured":"Xu J et al (2022) Progressive cortical and sub-cortical alterations in patients with anti-N-methyl-D-aspartate receptor encephalitis. J Neurol 269(1):389\u2013398","journal-title":"J Neurol"},{"key":"13571_CR69","volume":"406","author":"A Liu","year":"2025","unstructured":"Liu A et al (2025) Reversal of profound cortical atrophy with immunotherapy in pediatric anti-NMDA receptor encephalitis. J Neuroimmunol 406:578649","journal-title":"J Neuroimmunol"},{"issue":"4","key":"13571_CR70","volume":"12","author":"N Seery","year":"2025","unstructured":"Seery N et al (2025) Rituximab use for relapse prevention in anti-NMDAR antibody-mediated encephalitis: a multicenter cohort study. Neurol Neuroimmunol Neuroinflamm 12(4):e200395","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13571_CR71","volume":"565","author":"Y Lin","year":"2025","unstructured":"Lin Y et al (2025) Serum neuron-specific enolase can predict the severity and outcome of anti-N-methyl-D-aspartate receptor encephalitis. Clin Chim Acta 565:119962","journal-title":"Clin Chim Acta"},{"issue":"9","key":"13571_CR72","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1007\/s00415-023-11852-6","volume":"270","author":"D Shen","year":"2023","unstructured":"Shen D et al (2023) Correction to: Image features of anti-SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism. J Neurol 270(9):4554","journal-title":"J Neurol"},{"issue":"9","key":"13571_CR73","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1007\/s00415-023-11756-5","volume":"270","author":"D Shen","year":"2023","unstructured":"Shen D et al (2023) Image features of anti-SEZ6L2 encephalitis, a rare cause of ataxia and parkinsonism. J Neurol 270(9):4549\u20134553","journal-title":"J Neurol"},{"key":"13571_CR74","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200145","author":"A McKeon","year":"2023","unstructured":"McKeon A et al (2023) Utility of protein microarrays for detection of classified and novel antibodies in autoimmune neurologic disease. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000200145","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"9","key":"13571_CR75","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.biopsych.2015.02.024","volume":"79","author":"C Finke","year":"2016","unstructured":"Finke C et al (2016) Structural hippocampal damage following anti-N-methyl-D-aspartate receptor encephalitis. Biol Psychiatry 79(9):727\u2013734","journal-title":"Biol Psychiatry"},{"key":"13571_CR76","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2018.11.004","volume":"21","author":"F Albrecht","year":"2019","unstructured":"Albrecht F et al (2019) FDG-PET hypometabolism is more sensitive than MRI atrophy in Parkinson\u2019s disease: a whole-brain multimodal imaging meta-analysis. Neuroimage Clin 21:101594","journal-title":"Neuroimage Clin"},{"issue":"2","key":"13571_CR77","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2214\/AJR.18.19822","volume":"211","author":"K Zukotynski","year":"2018","unstructured":"Zukotynski K et al (2018) Pet\/CT of dementia. AJR Am J Roentgenol 211(2):246\u2013259","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"13571_CR78","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000200498","volume":"12","author":"A Farina","year":"2025","unstructured":"Farina A et al (2025) Serum neurofilament light chain correlates with clinical severity and predicts mortality in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm 12(6):e200498","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"1","key":"13571_CR79","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/s41392-023-01486-5","volume":"8","author":"W Zhang","year":"2023","unstructured":"Zhang W et al (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct Target Ther 8(1):267","journal-title":"Signal Transduct Target Ther"},{"key":"13571_CR80","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22147432","author":"T Behl","year":"2021","unstructured":"Behl T et al (2021) Current trends in neurodegeneration: cross talks between oxidative stress, cell death, and inflammation. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms22147432","journal-title":"Int J Mol Sci"},{"issue":"5","key":"13571_CR81","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.14336\/AD.2024.0986","volume":"15","author":"V Gupta","year":"2024","unstructured":"Gupta V, Chitranshi N, Gupta VB (2024) Genetic risk, inflammation, and therapeutics: an editorial overview of recent advances in aging brains and neurodegeneration. Aging Dis 15(5):1989\u20131993","journal-title":"Aging Dis"},{"key":"13571_CR82","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/B978-0-12-820683-6.00011-7","volume":"181","author":"S Chiloiro","year":"2021","unstructured":"Chiloiro S et al (2021) Hypothalamitis and pituitary atrophy. Handb Clin Neurol 181:149\u2013159","journal-title":"Handb Clin Neurol"},{"key":"13571_CR83","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000605","author":"C Gaig","year":"2019","unstructured":"Gaig C et al (2019) HLA and microtubule-associated protein tau H1 haplotype associations in anti-IgLON5 disease. Neurol Neuroimmunol Neuroinflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000605","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"13571_CR84","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1124\/pharmrev.120.000131","volume":"73","author":"KB Hansen","year":"2021","unstructured":"Hansen KB et al (2021) Structure, function, and pharmacology of glutamate receptor ion channels. Pharmacol Rev 73(4):298\u2013487","journal-title":"Pharmacol Rev"},{"key":"13571_CR85","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.sbi.2015.07.012","volume":"33","author":"MC Regan","year":"2015","unstructured":"Regan MC, Romero-Hernandez A, Furukawa H (2015) A structural biology perspective on NMDA receptor pharmacology and function. Curr Opin Struct Biol 33:68\u201375","journal-title":"Curr Opin Struct Biol"},{"issue":"12","key":"13571_CR86","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1038\/s41594-024-01386-4","volume":"31","author":"K Michalski","year":"2024","unstructured":"Michalski K et al (2024) Structural and functional mechanisms of anti-NMDAR autoimmune encephalitis. Nat Struct Mol Biol 31(12):1975\u20131986","journal-title":"Nat Struct Mol Biol"},{"issue":"5411","key":"13571_CR87","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1126\/science.284.5411.162","volume":"284","author":"K Shen","year":"1999","unstructured":"Shen K, Meyer T (1999) Dynamic control of CaMKII translocation and localization in hippocampal neurons by NMDA receptor stimulation. Science 284(5411):162\u2013166","journal-title":"Science"},{"issue":"1","key":"13571_CR88","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1002\/jnr.20422","volume":"80","author":"D Zhu","year":"2005","unstructured":"Zhu D et al (2005) N-methyl-D-aspartate and TrkB receptors protect neurons against glutamate excitotoxicity through an extracellular signal-regulated kinase pathway. J Neurosci Res 80(1):104\u2013113","journal-title":"J Neurosci Res"},{"issue":"2","key":"13571_CR89","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1046\/j.1471-4159.2001.00386.x","volume":"78","author":"RH Lipsky","year":"2001","unstructured":"Lipsky RH et al (2001) Nuclear factor kappaB is a critical determinant in N-methyl-D-aspartate receptor-mediated neuroprotection. J Neurochem 78(2):254\u2013264","journal-title":"J Neurochem"},{"issue":"9","key":"13571_CR90","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1523\/JNEUROSCI.19-09-03277.1999","volume":"19","author":"SV Bhave","year":"1999","unstructured":"Bhave SV, Ghoda L, Hoffman PL (1999) Brain-derived neurotrophic factor mediates the anti-apoptotic effect of NMDA in cerebellar granule neurons: signal transduction cascades and site of ethanol action. J Neurosci 19(9):3277\u20133286","journal-title":"J Neurosci"},{"issue":"6672","key":"13571_CR91","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/32448","volume":"392","author":"K Deisseroth","year":"1998","unstructured":"Deisseroth K, Heist EK, Tsien RW (1998) Translocation of calmodulin to the nucleus supports CREB phosphorylation in hippocampal neurons. Nature 392(6672):198\u2013202","journal-title":"Nature"},{"issue":"13","key":"13571_CR92","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1016\/j.celrep.2018.05.096","volume":"23","author":"L Lad\u00e9p\u00eache","year":"2018","unstructured":"Lad\u00e9p\u00eache L et al (2018) NMDA receptor autoantibodies in autoimmune encephalitis cause a subunit-specific nanoscale redistribution of NMDA receptors. Cell Rep 23(13):3759\u20133768","journal-title":"Cell Rep"},{"issue":"8","key":"13571_CR93","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.1093\/brain\/awae163","volume":"147","author":"Z Jamet","year":"2024","unstructured":"Jamet Z et al (2024) NMDA receptor autoantibodies primarily impair the extrasynaptic compartment. Brain 147(8):2745\u20132760","journal-title":"Brain"},{"issue":"11","key":"13571_CR94","first-page":"3144","volume":"141","author":"M Petit-Pedrol","year":"2018","unstructured":"Petit-Pedrol M et al (2018) LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory. Brain 141(11):3144\u20133159","journal-title":"Brain"},{"issue":"5794","key":"13571_CR95","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1126\/science.1129947","volume":"313","author":"Y Fukata","year":"2006","unstructured":"Fukata Y et al (2006) Epilepsy-related ligand\/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313(5794):1792\u20131795","journal-title":"Science"},{"issue":"23","key":"13571_CR96","doi-asserted-by":"crossref","first-page":"3436","DOI":"10.1093\/hmg\/ddl421","volume":"15","author":"MS Sirerol-Piquer","year":"2006","unstructured":"Sirerol-Piquer MS et al (2006) The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum Mol Genet 15(23):3436\u20133445","journal-title":"Hum Mol Genet"},{"issue":"46","key":"13571_CR97","doi-asserted-by":"crossref","first-page":"18161","DOI":"10.1523\/JNEUROSCI.3506-13.2013","volume":"33","author":"T Ohkawa","year":"2013","unstructured":"Ohkawa T et al (2013) Autoantibodies to epilepsy-related LGI1 in limbic encephalitis neutralize LGI1-ADAM22 interaction and reduce synaptic AMPA receptors. J Neurosci 33(46):18161\u201318174","journal-title":"J Neurosci"},{"issue":"5","key":"13571_CR98","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2022.103074","volume":"21","author":"N Seery","year":"2022","unstructured":"Seery N et al (2022) Contemporary advances in antibody-mediated encephalitis: anti-LGI1 and anti-Caspr2 antibody (Ab)-mediated encephalitides. Autoimmun Rev 21(5):103074","journal-title":"Autoimmun Rev"},{"issue":"3","key":"13571_CR99","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/ejn.14081","volume":"48","author":"M Saint-Martin","year":"2018","unstructured":"Saint-Martin M et al (2018) Contactin-associated protein-like 2, a protein of the neurexin family involved in several human diseases. Eur J Neurosci 48(3):1906\u20131923","journal-title":"Eur J Neurosci"},{"issue":"1","key":"13571_CR100","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/ana.25120","volume":"83","author":"KR Patterson","year":"2018","unstructured":"Patterson KR, Dalmau J, Lancaster E (2018) Mechanisms of Caspr2 antibodies in autoimmune encephalitis and neuromyotonia. Ann Neurol 83(1):40\u201351","journal-title":"Ann Neurol"},{"issue":"6","key":"13571_CR101","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1083\/jcb.200305018","volume":"162","author":"S Poliak","year":"2003","unstructured":"Poliak S et al (2003) Juxtaparanodal clustering of Shaker-like K+ channels in myelinated axons depends on Caspr2 and TAG-1. J Cell Biol 162(6):1149\u20131160","journal-title":"J Cell Biol"},{"issue":"6","key":"13571_CR102","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1083\/jcb.200305078","volume":"162","author":"M Traka","year":"2003","unstructured":"Traka M et al (2003) Association of TAG-1 with Caspr2 is essential for the molecular organization of juxtaparanodal regions of myelinated fibers. J Cell Biol 162(6):1161\u20131172","journal-title":"J Cell Biol"},{"issue":"2","key":"13571_CR103","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2024.09.004","volume":"6","author":"P Terroba-Navajas","year":"2025","unstructured":"Terroba-Navajas P et al (2025) Humoral signatures of Caspr2-antibody spectrum disorder track with clinical phenotypes and outcomes. Med 6(2):100515","journal-title":"Med"},{"issue":"1","key":"13571_CR104","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/ibra.12017","volume":"8","author":"YK Lv","year":"2022","unstructured":"Lv YK, Zhang HQ, Zhang J (2022) Research progress of anti-\u03b3-aminobutyric acid B receptor encephalitis and a case report of paraneoplastic associated encephalitis and treatment analysis. Ibrain 8(1):15\u201322","journal-title":"Ibrain"},{"issue":"2","key":"13571_CR105","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/physrev.00010.2016","volume":"97","author":"J Dalmau","year":"2017","unstructured":"Dalmau J, Geis C, Graus F (2017) Autoantibodies to synaptic receptors and neuronal cell surface proteins in autoimmune diseases of the central nervous system. Physiol Rev 97(2):839\u2013887","journal-title":"Physiol Rev"},{"issue":"3","key":"13571_CR106","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000232","volume":"3","author":"KS Golombeck","year":"2016","unstructured":"Golombeck KS et al (2016) Evidence of a pathogenic role for CD8(+) T cells in anti-GABAB receptor limbic encephalitis. Neurol Neuroimmunol Neuroinflamm 3(3):e232","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13571_CR107","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/7854_2021_222","volume":"52","author":"AP Princivalle","year":"2022","unstructured":"Princivalle AP (2022) GABA(B) receptors in neurodegeneration. Curr Top Behav Neurosci 52:267\u2013290","journal-title":"Curr Top Behav Neurosci"},{"issue":"5","key":"13571_CR108","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.4103\/1673-5374.355759","volume":"18","author":"YH Zhang","year":"2023","unstructured":"Zhang YH et al (2023) Anti-IgLON5 disease: a novel topic beyond neuroimmunology. Neural Regen Res 18(5):1017\u20131022","journal-title":"Neural Regen Res"},{"issue":"6","key":"13571_CR109","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00115-022-01411-1","volume":"94","author":"J Heine","year":"2023","unstructured":"Heine J et al (2023) Autoimmune encephalitis-an update. Nervenarzt 94(6):525\u2013537","journal-title":"Nervenarzt"},{"issue":"5","key":"13571_CR110","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1002\/ana.25857","volume":"88","author":"J Landa","year":"2020","unstructured":"Landa J et al (2020) Effects of IgLON5 antibodies on neuronal cytoskeleton: a link between autoimmunity and neurodegeneration. Ann Neurol 88(5):1023\u20131027","journal-title":"Ann Neurol"},{"issue":"5","key":"13571_CR111","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00234-024-03318-x","volume":"66","author":"F Sanvito","year":"2024","unstructured":"Sanvito F et al (2024) Autoimmune encephalitis: what the radiologist needs to know. Neuroradiology 66(5):653\u2013675","journal-title":"Neuroradiology"},{"issue":"2","key":"13571_CR112","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1093\/brain\/awac276","volume":"146","author":"F G\u00f6vert","year":"2023","unstructured":"G\u00f6vert F et al (2023) Distinct movement disorders in contactin-associated-protein-like-2 antibody-associated autoimmune encephalitis. Brain 146(2):657\u2013667","journal-title":"Brain"},{"issue":"4","key":"13571_CR113","volume":"100","author":"Y Pi","year":"2021","unstructured":"Pi Y, Zhang LL, Li JC (2021) Anti-IgLON5 disease with distinctive brain MRI findings responding to immunotherapy: a case report. Medicine (Baltimore) 100(4):e24384","journal-title":"Medicine (Baltimore)"},{"issue":"2","key":"13571_CR114","doi-asserted-by":"crossref","DOI":"10.1212\/NXI.0000000000000326","volume":"4","author":"G Berzero","year":"2017","unstructured":"Berzero G et al (2017) Paraneoplastic cerebellar degeneration associated with anti-ITPR1 antibodies. Neurol Neuroimmunol Neuroinflamm 4(2):e326","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"4","key":"13571_CR115","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/neu.2019.50","volume":"32","author":"JE Marinas","year":"2020","unstructured":"Marinas JE et al (2020) Neuroimmunological antibody-mediated encephalitis and implications for diagnosis and therapy in neuropsychiatry. Acta Neuropsychiatr 32(4):177\u2013185","journal-title":"Acta Neuropsychiatr"},{"key":"13571_CR116","first-page":"S162","volume":"67","author":"G Rebella","year":"2025","unstructured":"Rebella G et al (2025) BRAIN MRI FINDINGS IN AUTOIMMUNE ENCEPHALITIS: A MULTICENTER ANALYSIS FROM TWO REFERRAL CENTERS. Neuroradiology 67:S162\u2013S163","journal-title":"Neuroradiology"},{"issue":"1","key":"13571_CR117","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s13311-020-00921-7","volume":"18","author":"WJ Lee","year":"2021","unstructured":"Lee WJ et al (2021) Teratoma removal, steroid, IVIG, Rituximab and Tocilizumab (T-SIRT) in anti-NMDAR encephalitis. Neurotherapeutics 18(1):474\u2013487","journal-title":"Neurotherapeutics"},{"issue":"1","key":"13571_CR118","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41419-024-07263-8","volume":"11","author":"L Cheng","year":"2025","unstructured":"Cheng L et al (2025) Immunotherapy for autoimmune encephalitis. Cell Death Discov 11(1):8","journal-title":"Cell Death Discov"},{"key":"13571_CR119","first-page":"11","volume":"12","author":"J Yang","year":"2021","unstructured":"Yang J, Liu X (2021) Immunotherapy for refractory autoimmune encephalitis. Front Immunol 12:11","journal-title":"Front Immunol"},{"issue":"3","key":"13571_CR120","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/WCO.0000000000000443","volume":"30","author":"R Dale","year":"2017","unstructured":"Dale R, Gorman M, Lim M (2017) Autoimmune encephalitis in children: clinical phenomenology, therapeutics, and emerging challenges. Curr Opin Neurol 30(3):334\u2013344","journal-title":"Curr Opin Neurol"},{"issue":"6","key":"13571_CR121","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1017\/cjn.2024.16","volume":"51","author":"C Hahn","year":"2024","unstructured":"Hahn C et al (2024) Canadian consensus guidelines for the diagnosis and treatment of autoimmune encephalitis in adults. Can J Neurol Sci 51(6):734\u2013754","journal-title":"Can J Neurol Sci"},{"key":"13571_CR122","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1212\/01.wnl.0000903148.02345.a9","volume":"99","author":"L Manrique-Trujillo","year":"2022","unstructured":"Manrique-Trujillo L, Franada T (2022) Spectrum of brain MRI features in CASPR2 associated autoimmune encephalitis: a case report with parietal lobe involvement. Neurology 99:S15\u2013S16","journal-title":"Neurology"},{"issue":"1-2","key":"13571_CR123","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jneuroim.2013.05.011","volume":"261","author":"YC Wei","year":"2013","unstructured":"Wei YC et al (2013) Rapid progression and brain atrophy in anti-AMPA receptor encephalitis. J Neuroimmunol 261(1\u20132):129\u2013133","journal-title":"J Neuroimmunol"},{"issue":"2","key":"13571_CR124","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00415-019-09585-6","volume":"267","author":"F Scheibe","year":"2020","unstructured":"Scheibe F et al (2020) Daratumumab treatment for therapy-refractory anti-CASPR2 encephalitis. J Neurol 267(2):317\u2013323","journal-title":"J Neurol"},{"issue":"10","key":"13571_CR125","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1111\/cns.14280","volume":"29","author":"C Zhang","year":"2023","unstructured":"Zhang C et al (2023) Comprehensive analyses of brain cell communications based on multiple scRNA-seq and snRNA-seq datasets for revealing novel mechanism in neurodegenerative diseases. CNS Neurosci Ther 29(10):2775\u20132786","journal-title":"CNS Neurosci Ther"},{"issue":"3","key":"13571_CR126","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41588-021-00801-6","volume":"53","author":"J Jerber","year":"2021","unstructured":"Jerber J et al (2021) Population-scale single-cell RNA-seq profiling across dopaminergic neuron differentiation. Nat Genet 53(3):304\u2013312","journal-title":"Nat Genet"},{"issue":"6616","key":"13571_CR127","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1126\/science.abh4340","volume":"378","author":"PT Toi","year":"2022","unstructured":"Toi PT et al (2022) In vivo direct imaging of neuronal activity at high temporospatial resolution. Science 378(6616):160\u2013168","journal-title":"Science"},{"issue":"18","key":"13571_CR128","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz3025","volume":"6","author":"PD Baksh","year":"2020","unstructured":"Baksh PD et al (2020) Quantitative and correlative extreme ultraviolet coherent imaging of mouse hippocampal neurons at high resolution. Sci Adv 6(18):eaaz3025","journal-title":"Sci Adv"},{"key":"13571_CR129","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neuroscience.2015.05.037","volume":"309","author":"J Heine","year":"2015","unstructured":"Heine J et al (2015) Imaging of autoimmune encephalitis\u2013relevance for clinical practice and hippocampal function. Neuroscience 309:68\u201383","journal-title":"Neuroscience"},{"issue":"3","key":"13571_CR130","volume":"32","author":"J Wang","year":"2025","unstructured":"Wang J et al (2025) Microglial activation visualized by [(18)F]-DPA714 PET is a potential marker of severity and prognosis for anti-LGI1 encephalitis. Eur J Neurol 32(3):e70107","journal-title":"Eur J Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13571-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13571-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T12:58:08Z","timestamp":1773665888000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13571-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,19]]},"references-count":130,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["13571"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13571-6","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,19]]},"assertion":[{"value":"15 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 December 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The author(s) declare no potential conflicts of interest with respect to the research, authorship, and\/or publication of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"This review contains MR images and clinical data of patients from our center, and written permission for the use of these materials has been obtained from the patients or their legally authorized representatives.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from all participants or their legally authorized representatives prior to participation.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Written informed consent for the publication of anonymized data was obtained from all participants or their legally authorized representatives. No identifying information is included in the manuscript.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"32"}}